Amgen (AMGN) PT Raised to $260 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $458.55 +1.49%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 23 | New: 16
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 23 | New: 16
Join SI Premium – FREE
Piper Sandler analyst Christopher Raymond raised the price target on Amgen (NASDAQ: AMGN) to $260.00 (from $255.00) while maintaining a Overweight rating.
You May Also Be Interested In
- FDA: Amgen Vectibix promotional video found false or misleading
- AMERISAFE (AMSF) PT Lowered to $35 at Citizens on Top and Bottom Line Miss
- Silicon Motion Technology (SIMO) PT Raised to $310 at B.Riley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
